Skip to main content
OpenTrials

Clinical trial condition

Demyelinating Diseases

Explore clinical trials studying Demyelinating Diseases. Study availability and eligibility vary by location and protocol.

2,934 public trials 459 recruiting studies
Refine in advanced search Browse all conditions

Demyelinating Diseases trial results

Completed

Supplementation of VigantOL® Oil Versus Placebo as Add-on in Patients With Relapsing Remitting Multiple Sclerosis Receiving Rebif® Treatment

NCT01285401

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Research Site Vienna, Austria
  • Research Site Esbjerg, Denmark
  • Research Site Glostrup Municipality, Denmark
  • Research Site Sønderborg, Denmark
View all 38 locations
View Trial Details
Completed

Safety Study of Olesoxime in Patients With Stable Relapsing Remitting Multiple Sclerosis Treated With Interferon Beta.

NCT01808885

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Timone University Hospital, Neurology Department, UMR CRMBM CNRS 6612 Marseille, France
  • CHU Reims, Maison Blanche Hospital, Neurology Department & University of Reims Reims, France
  • CHU Pontchaillou, Neurology Department Rennes, France
View Trial Details
Completed

Biomarker Study After Initiation of Treatment With Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis

NCT01310166

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Novartis Investigative Site Ostfildern, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Altenholz-Stift, Germany
  • Novartis Investigative Site Andernach, Germany
  • Novartis Investigative Site Celle, Germany
View all 61 locations
View Trial Details

Related conditions